Nutritional science has documented consistent relationships between specific micronutrient deficiencies and both chronic pain conditions and depression — magnesium deficiency has been linked to enhanced pain sensitivity and lower pain thresholds, B-vitamin inadequacy affects the neurotransmitter synthesis pathways underlying mood regulation, and vitamin D deficiency is associated with both depressive symptoms and increased pain sensitivity in multiple population studies. For patients managing chronic pain and depression simultaneously, the question of whether their nutritional status is contributing to their symptom burden is clinically reasonable — and for patients who have undergone significant medical treatment, are managing stress-related depletion, or have absorption challenges that limit what oral supplements can achieve, IV therapy offers a direct route to repleting what the body needs. At EleMental Health in Boise, IV therapy is offered as a supportive element within our broader ketamine and pain treatment practice, grounded in clinical rationale rather than wellness-industry enthusiasm.
Why Nutrition Is Relevant to Both Chronic Pain and Depression
The relationship between nutritional status and both chronic pain and mood disorders is more mechanistically grounded than the general public often realizes. Magnesium is directly relevant to pain biology through the NMDA receptor — the same receptor that ketamine targets for both pain and depression treatment. NMDA receptors require magnesium for normal gating function; when magnesium levels are inadequate, NMDA receptor overactivation may contribute to central sensitization and amplified pain responses. Research from the National Institutes of Health documents that low magnesium status correlates with lower pain thresholds and may worsen pain sensitivity in conditions including neuropathic pain and fibromyalgia.
For depression, the B-vitamin pathways are particularly significant. Folate (B9), methylcobalamin (B12), and pyridoxal-5-phosphate (active B6) are cofactors in the enzymatic reactions that synthesize serotonin, dopamine, and norepinephrine. Deficiencies in these cofactors can limit the brain’s ability to maintain adequate neurotransmitter production — a foundational issue that antidepressants alone cannot fully compensate for. Patients with MTHFR gene variants, which are common in the general population, have impaired folate metabolism that reduces their conversion of dietary folate into the active methylfolate required for neurotransmitter synthesis. IV administration of activated B vitamins bypasses this metabolic bottleneck, delivering the cofactors in their immediately usable form.
Oxidative stress and systemic inflammation are increasingly recognized as contributors to both chronic pain amplification and depression in specific patient subsets. Glutathione — the body’s primary intracellular antioxidant — depletes under conditions of chronic illness, significant physiological stress, or extensive medical treatment. IV glutathione replenishment supports oxidative stress reduction in a way that oral precursors, which must be converted inside cells, may not achieve as efficiently in depleted patients.
How IV Therapy Fits Within a Ketamine Treatment Plan
At EleMental Health, IV therapy is most commonly used in the context of supporting ketamine treatment — either as preparation before a series begins or as adjunctive support during or after an induction course. This clinical rationale is specific rather than general: ketamine’s neuroplastic effects require an adequately nourished brain to fully manifest and consolidate. The synaptogenesis and BDNF-driven neuroplastic changes that make ketamine antidepressant require cellular machinery — amino acids, cofactors, energy substrates — to build and maintain new synaptic connections.
Patients who arrive for IV ketamine therapy in Boise in a state of significant nutritional depletion — common in patients who have been managing chronic pain and depression for years, who have had disrupted appetite and sleep, and who may have used medications that deplete specific nutrients — may experience reduced ketamine response or less durable effects than patients whose nutritional foundation is adequate. Addressing significant deficiencies before or alongside ketamine treatment is a reasonable strategy for optimizing the biological conditions under which ketamine works.
IV therapy at our clinic is not administered as a standalone treatment for depression, chronic pain, or any other specific condition. We do not claim that a vitamin infusion will cure fibromyalgia or eliminate treatment-resistant depression. What we offer is clinically justified nutritional support within a treatment context where the rationale is specific and grounded in the mechanisms of the co-administered primary treatments.
What EleMental Health’s IV Therapy Involves
Our premium IV therapy services in Boise, ID begin with a clinical intake review, not simply an online questionnaire. Nykol Bailey Rice, CRNA, PMHNP, reviews your symptom profile, current medications, medical history, and treatment context to identify the formulation that makes the most clinical sense for your specific situation. Standard formulations may include combinations of magnesium, B-complex vitamins including methylfolate and methylcobalamin, vitamin C, zinc, and glutathione — but the specific composition is selected based on clinical context rather than a one-size-fits-all wellness menu.
Sessions are administered in our clinic with an IV line placed and the infusion running over approximately 30 to 60 minutes. Patients typically find the experience comfortable. Common post-session reports include improved energy levels, a sense of physical ease, or reduced tension — though the character and timing of response varies considerably between individuals. Results vary by individual, and we communicate this clearly rather than overpromising what a session will produce.
Nykol’s CRNA background is relevant even to IV therapy administration. Patients with complex cardiovascular profiles, multiple medications, or IV access challenges benefit from the level of clinical expertise she brings to the administration process. The same careful monitoring and pharmacological awareness that informs ketamine infusion management applies to IV therapy at our clinic.
Addressing Skepticism About IV Vitamin Therapy
We acknowledge the legitimate skepticism that exists about IV vitamin therapy. The wellness industry’s track record of exaggerated claims — IV therapy marketed as detoxification, cancer prevention, or disease reversal — has reasonably made patients and clinicians suspicious of the entire category. Our perspective is that the skepticism is warranted toward the exaggerated claims but not toward the underlying pharmacological rationale for IV delivery in specific, justified clinical contexts.
If your nutritional status is adequate, you are not depleted by chronic illness or significant physiological stress, and you are not undergoing concurrent interventional treatment that could benefit from nutritional optimization, a vitamin infusion is unlikely to produce meaningful clinical benefit. We will tell you this if it applies to your situation, because honest clinical assessment is more valuable to patients than maximizing our service volume. The goal is appropriate use — recommending IV therapy when there is a specific clinical rationale and being transparent when that rationale isn’t present.
One barrier to IV therapy for some patients is cost. IV therapy is generally not covered by insurance for the wellness or adjunctive support indications most relevant to our practice, making it a cash-pay service. Costs vary by formulation and session count. We discuss these figures during consultation rather than leaving patients to discover them after deciding to proceed. Financing options including Advance Care Card are available for patients who benefit from payment flexibility.
A second consideration is practicality. Some patients who are already managing twice-weekly ketamine sessions, SPRAVATO® appointments, or other treatment commitments find that adding IV therapy to their schedule is not feasible during active treatment. We discuss timing in those situations — whether IV therapy makes more sense as preparation before a treatment series, as recovery support afterward, or as intermittent maintenance during a less intensive treatment phase. For a broader look at the pros and cons of vitamin IV therapy, our blog explores the evidence in more depth.
Frequently Asked Questions
Is IV therapy just an expensive version of oral supplements?
For many patients in good health with adequate absorption and no specific depletion, oral supplements are sufficient and more cost-effective. IV therapy has clinical advantages for patients with impaired GI absorption, documented deficiencies that oral dosing hasn’t corrected, or specific needs for rapid repletion — such as the nutritional support context of active ketamine treatment. Discuss your specific situation with your provider.
How often should I schedule IV therapy sessions?
Frequency depends on your clinical situation and goals. Some patients benefit from a brief series during active treatment, then reduce to monthly maintenance. Others use IV therapy only as preparation before a ketamine course. Your provider will recommend a schedule based on your specific context.
Can IV therapy help with neuropathy pain specifically?
B vitamins, particularly methylcobalamin, have documented roles in nerve health and neuropathic pain management. Magnesium’s NMDA receptor effects are relevant to neuropathic pain amplification. IV therapy is not a primary treatment for neuropathy, but as adjunctive support within a broader pain treatment plan, it has a coherent rationale for some patients.
Are there any risks to IV therapy?
Risks are generally low when administered by qualified clinical providers with appropriate intake review. Common minor risks include discomfort or bruising at the IV site, and transient side effects (warmth, lightheadedness) that are managed by adjusting infusion rate. Our intake process identifies any contraindications specific to your medical history and medications.
Does Nykol Bailey Rice recommend IV therapy for all ketamine patients?
No. IV therapy is recommended when there is a specific clinical rationale — nutritional depletion, poor absorption, preparation for intensive treatment, or adjunctive support during an active ketamine course. Patients who do not have clear indication for IV therapy are not routinely recommended it.
Key Takeaways
- Magnesium, B-complex vitamins, and antioxidants like glutathione have documented roles in NMDA receptor function, neurotransmitter synthesis, and oxidative stress — directly relevant to both chronic pain and depression.
- IV delivery achieves plasma and intracellular concentrations that oral supplementation may not match, particularly for patients with absorption challenges or significant depletion.
- At EleMental Health, IV therapy is used as adjunctive support within a ketamine treatment context, not as a standalone cure for any condition.
- Formulations are selected based on individual clinical assessment, not a one-size-fits-all wellness menu.
- IV therapy is generally a cash-pay service; clinical justification, honest cost communication, and appropriate patient selection guide how it is used in our practice.
Conclusion
Nutritional status is not an afterthought in the treatment of chronic pain and depression — it is a foundational substrate that affects how every other intervention works. For patients at EleMental Health who are undertaking ketamine infusion series, managing chronic pain alongside depression, or recovering from years of physiological depletion, IV therapy offers a targeted way to address nutritional factors that are clinically relevant to their treatment outcomes. Nykol Bailey Rice’s dual CRNA and PMHNP credentials mean that IV therapy at our practice is administered with the same clinical rigor applied to every other service we offer. Call 208-801-1414 or contact us to schedule a consultation and discuss whether IV therapy has a role in your care plan.
References
National Institutes of Health. Magnesium and pain sensitivity. https://pmc.ncbi.nlm.nih.gov/articles/PMC5487054/
National Institutes of Health. B vitamins and neurotransmitter synthesis. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772032/
National Institutes of Health. Glutathione and oxidative stress in chronic illness. https://pmc.ncbi.nlm.nih.gov/articles/PMC5801167/
About Nykol Bailey Rice, CRNA, PMHNP
Nykol Bailey Rice, CRNA, PMHNP, is the lead clinician at EleMental Health in Boise, ID, bringing the rare combination of nurse anesthesia and psychiatric nurse practitioner training to the treatment of patients with chronic pain and co-occurring depression. This dual credential is particularly relevant for patients whose care sits at the intersection of anesthetic safety — requiring real-time monitoring and pharmacological expertise — and psychiatric complexity, where understanding the relationship between pain and mood is essential to effective treatment planning. EleMental Health offers IV ketamine, IM ketamine, compounded nasal spray ketamine, and ketamine-assisted therapy for patients with chronic pain, neuropathy, fibromyalgia, and co-occurring mood disorders.
Medical Disclaimer
The information in this blog post is for educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. IV therapy should only be pursued under the supervision of qualified licensed providers familiar with your complete medical history and current medications. Individual results vary. If you are experiencing a mental health crisis or thoughts of self-harm, please call or text 988 to reach the Suicide and Crisis Lifeline or go to your nearest emergency room.